- Status Complete
- Type New application
- Pre-PASC consultation -
- Pre-MSAC consultation -
- Outcome Deferred
Application details
Reason for application
New MBS item.
Service or technology in this application
In-situ hybridisation (ISH) for PBS listing of trastuzumab.
Type: Investigative
Medical condition this application addresses
Previously untreated human epidermal growth factor receptor 2 (HER2) positive inoperable locally advanced or metastatic gastric or gastro-oesophageal cancer.
Application documents
PICO confirmation
Public summary document
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Meetings to consider this application
- PASC meeting: 7 July 2011
- ESC meeting: 11 - 12 October 2012
- MSAC meeting: 29 - 30 November 2012